Aurobindo Pharma Ltd

NSE: AUROPHARMA · BSE: 524804 · Pharmaceuticals & Biotechnology · 63 announcements

Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,680.80
Market cap: ₹97,621 Cr
Revenue (annual): ₹33,653 Cr
Net profit (annual): ₹3,505 Cr
P/E (TTM): 24.8×Sector 47.4×
Promoter holding: 51.88%+0.06% QoQ
FII holding: 16.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

21 May 2026 22:26 IST NSE

Aurobindo Pharma Board Meeting Outcome

Aurobindo Pharma appointed RPR & Associates and Ernst & Young LLP as secretarial and internal auditors. The board meeting also accepted MRR & Associates' resignation.

Execution: 60 months

Read the filing ↗